Apitegromab
Apitegromab is a pharmaceutical drug with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
3
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
EAP of Apitegromab for Patients With Spinal Muscular Atrophy
Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam
Clinical Trials (6)
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
EAP of Apitegromab for Patients With Spinal Muscular Atrophy
Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6